Mectizan Expert Committee/Albendazole Coordination

The Mectizan Expert Committee/Albendazole Coordination (MEC/AC) is an independent body of nine internationally recognized experts in the fields of public health, tropical disease, ophthalmology, social science, and other disciplines, established by Merck & Co., Inc., Kenilworth, N.J., U.S.A.* to provide technical oversight of the Mectizan Donation Program. With the exception of the Chair, MEC/AC members are appointed for two- to three-year terms and meet twice annually.

The MEC/AC also serves as a coordination body for the donation of albendazole by GSK in countries where river blindness is co-endemic and in countries eligible for IDA. The MEC/AC s Albendazole Coordination (AC) efforts ensure that the donations of Mectizan and albendazole are coordinated to combat LF effectively. The MEC/AC provides scientific, medical, and technical oversight of the donation of Mectizan to ensure it is used with good medical practice and to ensure the donation is stewarded effectively.

Liaison Organizations

  • Centers for Disease Control and Prevention
  • GlaxoSmithKline
  • Merck & Co., Inc.*
  • WHO
  • WHO AFRO
  • WHO EMRO
  • WHO PAHO
  • WHO SEARO
  • WHO WPRO
  • LF Regional Program Review Group

*Merck & Co., Inc., Kenilworth, N.J., U.S.A., is known as MSD outside of the United States and Canada.